Evidence map›Paper›PMID 34771844›Full record

ReviewMaterials (Basel, Switzerland)2021

Metal Nanoparticles and Carbon-Based Nanomaterials for Improved Performances of Electrochemical (Bio)Sensors with Biomedical Applications.

Luminita Fritea, Florin Banica, Traian Octavian Costea, Liviu Moldovan, Luciana Dobjanschi, Mariana Muresan, Simona Cavalu

Open access · goldAbstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers.

0numbers the graph read from it
0cells of the map it votes in
67citing papers in PubMed
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

67 citing papers in PubMed, 266 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

7 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Luminita FriteaFaculty of Medicine and Pharmacy, University of Oradea, 10 P-ta 1 Decembrie, 410087 Oradea, Romania.
Florin BanicaFaculty of Medicine and Pharmacy, University of Oradea, 10 P-ta 1 Decembrie, 410087 Oradea, Romania.
Traian Octavian CosteaAdvanced Materials Research Infrastructure-SMARTMAT, University of Oradea, 1 Universitatii Street, 410087 Oradea, Romania.
Liviu MoldovanFaculty of Electrical Engineering and Information Technology, University of Oradea, 1 Universitatii Street, 410087 Oradea, Romania.
Luciana DobjanschiFaculty of Medicine and Pharmacy, University of Oradea, 10 P-ta 1 Decembrie, 410087 Oradea, Romania.
Mariana MuresanFaculty of Medicine and Pharmacy, University of Oradea, 10 P-ta 1 Decembrie, 410087 Oradea, Romania.
Simona CavaluFaculty of Medicine and Pharmacy, University of Oradea, 10 P-ta 1 Decembrie, 410087 Oradea, Romania.ORCID 0000-0001-7810-8925
University of Oradea · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Monitoring human health for early detection of disease conditions or health disorders is of major clinical importance for maintaining a healthy life. Sensors are small devices employed for qualitative and quantitative determination of various analytes by monitoring their properties using a certain transduction method. A "real-time" biosensor includes a biological recognition receptor (such as an antibody, enzyme, nucleic acid or whole cell) and a transducer to convert the biological binding event to a detectable signal, which is read out indicating both the presence and concentration of the analyte molecule. A wide range of specific analytes with biomedical significance at ultralow concentration can be sensitively detected. In nano(bio)sensors, nanoparticles (NPs) are incorporated into the (bio)sensor design by attachment to the suitably modified platforms. For this purpose, metal nanoparticles have many advantageous properties making them useful in the transducer component of the (bio)sensors. Gold, silver and platinum NPs have been the most popular ones, each form of these metallic NPs exhibiting special surface and interface features, which significantly improve the biocompatibility and transduction of the (bio)sensor compared to the same process in the absence of these NPs. This comprehensive review is focused on the main types of NPs used for electrochemical (bio)sensors design, especially screen-printed electrodes, with their specific medical application due to their improved analytical performances and miniaturized form. Other advantages such as supporting real-time decision and rapid manipulation are pointed out. A special attention is paid to carbon-based nanomaterials (especially carbon nanotubes and graphene), used by themselves or decorated with metal nanoparticles, with excellent features such as high surface area, excellent conductivity, effective catalytic properties and biocompatibility, which confer to these hybrid nanocomposites a wide biomedical applicability.

Indexed as

biomedical applicationscarbon-based nanomaterialselectrochemical (bio)sensorsmetal nanoparticlesscreen-printed electrodes

Identifiers

PMID34771844
PMCPMC8585379
OpenAlexW3209776606

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.